ROPINIROLE

ROPINIROLE was reported 15621 times

ROPINIROLE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RESTLESS LEG AUGMENTATION SYNDROME 33 0.2129
1 DOPAMINE DYSREGULATION SYNDROME 71 0.1592
2 PARKINSONISM HYPERPYREXIA SYNDROME 18 0.1006
3 JEALOUS DELUSION 25 0.0883
4 STOMA SITE REACTION 44 0.0642
5 STOMA SITE ODOUR 12 0.0536
6 STOMA SITE ERYTHEMA 98 0.0524
7 HYPERSEXUALITY 88 0.0481
8 FREEZING PHENOMENON 176 0.0475
9 STOMA SITE DISCHARGE 129 0.0471
10 ON AND OFF PHENOMENON 261 0.0470
11 IMPULSE-CONTROL DISORDER 96 0.0466
12 DROPPED HEAD SYNDROME 18 0.0456
13 PARKINSONIAN GAIT 28 0.0449
14 STOMA SITE IRRITATION 24 0.0441
15 STOMA SITE PAIN 58 0.0395
16 FIBROMA 35 0.0381
17 GAMBLING 43 0.0369
18 COMPULSIVE SHOPPING 73 0.0355
19 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 14 0.0348
20 SLEEP ATTACKS 16 0.0336
21 DEEP BRAIN STIMULATION 20 0.0331
22 COMPULSIONS 22 0.0330
23 REDUCED FACIAL EXPRESSION 33 0.0325
24 STEREOTYPY 30 0.0318
25 EUTHANASIA 10 0.0315
26 HYPERKINESIA 64 0.0302
27 PERIODIC LIMB MOVEMENT DISORDER 11 0.0299
28 STOMA SITE INFLAMMATION 21 0.0281
29 STOMA SITE INFECTION 36 0.0276
30 STOMA SITE HYPERGRANULATION 17 0.0269
31 SEXUALLY INAPPROPRIATE BEHAVIOUR 11 0.0236
32 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 23 0.0217
33 PATHOLOGICAL GAMBLING 35 0.0211
34 GAMBLING DISORDER 56 0.0207
35 BRADYKINESIA 122 0.0206
36 RESTLESS LEGS SYNDROME 348 0.0191
37 STOMA SITE HAEMORRHAGE 29 0.0188
38 STOMA COMPLICATION 19 0.0187
39 DEVICE LOOSENING 16 0.0185
40 OCCIPITAL NEURALGIA 10 0.0177
41 BINGE EATING 19 0.0176
42 COMPULSIVE SEXUAL BEHAVIOUR 14 0.0173
43 RESTING TREMOR 11 0.0170
44 REBOUND ACID HYPERSECRETION 51 0.0168
45 DERMATILLOMANIA 10 0.0168
46 PLEUROTHOTONUS 15 0.0166
47 LIBIDO INCREASED 33 0.0163
48 NEPHROGENIC ANAEMIA 72 0.0155
49 MUSCLE RIGIDITY 185 0.0155
50 SUDDEN ONSET OF SLEEP 20 0.0144
51 THERAPEUTIC PRODUCT EFFECT VARIABLE 55 0.0142
52 OROMANDIBULAR DYSTONIA 10 0.0137
53 DYSKINESIA 530 0.0130
54 HALLUCINATION, VISUAL 273 0.0129
55 HYPERPARATHYROIDISM SECONDARY 32 0.0128
56 IMPULSIVE BEHAVIOUR 46 0.0122
57 PARKINSON'S DISEASE 31 0.0122
58 TENSION 73 0.0120
59 ACUTE PSYCHOSIS 28 0.0113
60 HALLUCINATION 766 0.0102
61 INFUSION SITE INDURATION 15 0.0101
62 ACQUIRED HAEMOPHILIA 10 0.0100
63 POSTURE ABNORMAL 32 0.0098
64 ILLUSION 16 0.0097
65 BEHAVIOUR DISORDER 52 0.0096
66 OBSESSIVE THOUGHTS 17 0.0094
67 BLEEDING TIME PROLONGED 11 0.0091
68 DELUSION 134 0.0086
69 LOGORRHOEA 30 0.0085
70 YAWNING 22 0.0082
71 REHABILITATION THERAPY 30 0.0077
72 ABNORMAL SLEEP-RELATED EVENT 10 0.0076
73 OBSESSIVE-COMPULSIVE DISORDER 60 0.0075
74 NONSPECIFIC REACTION 41 0.0075
75 HALLUCINATIONS, MIXED 31 0.0074
76 HYPOMANIA 27 0.0073
77 ANTICHOLINERGIC SYNDROME 11 0.0069
78 PSYCHOTIC SYMPTOM 14 0.0068
79 FULL BLOOD COUNT ABNORMAL 70 0.0066
80 DYSCHEZIA 20 0.0065
81 NOCTURIA 79 0.0065
82 INFUSION SITE BRUISING 14 0.0065
83 SLEEP TALKING 11 0.0065
84 PARKINSONISM 63 0.0065
85 AKINESIA 13 0.0063
86 TOXIC ENCEPHALOPATHY 31 0.0061
87 ESSENTIAL HYPERTENSION 11 0.0060
88 LIVING IN RESIDENTIAL INSTITUTION 11 0.0059
89 END STAGE RENAL DISEASE 106 0.0058
90 GASTROINTESTINAL HYPOMOTILITY 13 0.0058
91 SKIN ABRASION 27 0.0057
92 DEVICE CONNECTION ISSUE 12 0.0057
93 POTENTIATING DRUG INTERACTION 19 0.0057
94 CHRONIC KIDNEY DISEASE 428 0.0056
95 COMA SCALE ABNORMAL 16 0.0055
96 VOLVULUS 13 0.0055
97 PRODUCT RESIDUE PRESENT 29 0.0054
98 INFUSION SITE REACTION 16 0.0054
99 SUSPECTED SUICIDE 25 0.0053
100 DYSTONIA 103 0.0053
101 PERSECUTORY DELUSION 13 0.0052
102 SLEEP DEFICIT 11 0.0052
103 INFUSION SITE INFECTION 12 0.0052
104 URINARY TRACT OBSTRUCTION 12 0.0051
105 THERAPEUTIC PRODUCT EFFECT DELAYED 23 0.0050
106 POLYP 33 0.0050
107 SPINAL STENOSIS 20 0.0048
108 ATRIOVENTRICULAR BLOCK FIRST DEGREE 21 0.0048
109 DEVICE OCCLUSION 68 0.0048
110 INFREQUENT BOWEL MOVEMENTS 12 0.0048
111 FLUID INTAKE REDUCED 24 0.0048
112 BOWEL MOVEMENT IRREGULARITY 36 0.0047
113 METABOLIC ENCEPHALOPATHY 14 0.0047
114 FAECES HARD 18 0.0046
115 ENERGY INCREASED 27 0.0046
116 ABNORMAL DREAMS 126 0.0046
117 FINE MOTOR SKILL DYSFUNCTION 13 0.0045
118 HYPOKINESIA 65 0.0045
119 SEROTONIN SYNDROME 86 0.0045
120 VITAMIN B12 DEFICIENCY 18 0.0044
121 INTERVERTEBRAL DISC DEGENERATION 41 0.0044
122 IMPAIRED GASTRIC EMPTYING 60 0.0044
123 WALKING AID USER 29 0.0044
124 DEVICE KINK 16 0.0044
125 MEAN CELL VOLUME INCREASED 11 0.0043
126 MIDDLE INSOMNIA 80 0.0043
127 FIBULA FRACTURE 12 0.0042
128 ORTHOSTATIC HYPOTENSION 72 0.0041
129 MICTURITION DISORDER 14 0.0040
130 SLEEP APNOEA SYNDROME 77 0.0040
131 INITIAL INSOMNIA 41 0.0040
132 FACIAL PARESIS 14 0.0040
133 BALANCE DISORDER 335 0.0039
134 POSTMENOPAUSAL HAEMORRHAGE 10 0.0038
135 PARANOIA 66 0.0038
136 CEREBRAL ATROPHY 15 0.0038
137 POOR QUALITY SLEEP 81 0.0038
138 NEUROLEPTIC MALIGNANT SYNDROME 44 0.0037
139 CHONDROPATHY 10 0.0037
140 SOMNAMBULISM 24 0.0037
141 HOSPICE CARE 36 0.0036
142 PSYCHOTIC DISORDER 107 0.0036
143 DROOLING 25 0.0036
144 DELIRIUM 123 0.0035
145 MOTOR DYSFUNCTION 36 0.0035
146 OXYGEN SATURATION ABNORMAL 10 0.0035
147 COGNITIVE DISORDER 164 0.0035
148 HYPERPHAGIA 14 0.0035
149 INCONTINENCE 37 0.0035
150 SCREAMING 22 0.0035
151 ABNORMAL FAECES 28 0.0034
152 NECK INJURY 10 0.0034
153 DEPRESSIVE SYMPTOM 12 0.0034
154 SALIVARY HYPERSECRETION 34 0.0034
155 HYPERSOMNIA 97 0.0034
156 ATYPICAL PNEUMONIA 10 0.0033
157 SPEECH DISORDER 172 0.0033
158 STRESS CARDIOMYOPATHY 19 0.0033
159 MOBILITY DECREASED 233 0.0032
160 FALL 1077 0.0032
161 FEELING DRUNK 24 0.0032
162 APATHY 47 0.0032
163 ENURESIS 13 0.0032
164 ABNORMAL BEHAVIOUR 127 0.0032
165 SPINAL FUSION SURGERY 13 0.0032
166 BLOOD BLISTER 10 0.0032
167 DYSPHEMIA 14 0.0032
168 TORSADE DE POINTES 25 0.0032
169 INFUSION SITE SWELLING 20 0.0032
170 SELF-MEDICATION 13 0.0032
171 DEMENTIA 88 0.0031
172 NEUTROPHIL COUNT INCREASED 32 0.0031
173 DYSSTASIA 91 0.0031
174 HIP FRACTURE 100 0.0031
175 ECONOMIC PROBLEM 47 0.0031
176 DIZZINESS POSTURAL 30 0.0031
177 MENISCUS INJURY 19 0.0031
178 TREMOR 511 0.0031
179 SPONDYLITIS 11 0.0030
180 UNRESPONSIVE TO STIMULI 78 0.0030
181 GASTROOESOPHAGEAL REFLUX DISEASE 243 0.0030
182 ASPIRATION 33 0.0030
183 PRESCRIBED UNDERDOSE 60 0.0030
184 IMMOBILE 13 0.0030
185 INFUSION SITE ERYTHEMA 25 0.0030
186 HAND FRACTURE 21 0.0030
187 HAEMORRHAGIC ANAEMIA 13 0.0030
188 EXERCISE TOLERANCE DECREASED 17 0.0030
189 BLOOD IRON DECREASED 35 0.0029
190 LIGAMENT SPRAIN 29 0.0029
191 TYPE 2 DIABETES MELLITUS 98 0.0029
192 HEAD INJURY 92 0.0029
193 HUMERUS FRACTURE 14 0.0029
194 CERVICAL VERTEBRAL FRACTURE 10 0.0029
195 FOOT DEFORMITY 32 0.0029
196 HYPOPNOEA 10 0.0029
197 SKIN LACERATION 31 0.0028
198 GAIT INABILITY 95 0.0028
199 GAIT DISTURBANCE 543 0.0028
200 HYPERPYREXIA 12 0.0028
201 MOVEMENT DISORDER 91 0.0028
202 HALLUCINATION, AUDITORY 45 0.0028
203 MENTAL STATUS CHANGES 78 0.0028
204 BODY HEIGHT DECREASED 30 0.0028
205 PRODUCT DISPENSING ISSUE 12 0.0028
206 RIB FRACTURE 57 0.0028
207 RENAL INJURY 82 0.0028
208 RESTLESSNESS 101 0.0028
209 BIPOLAR DISORDER 30 0.0028
210 FORMICATION 19 0.0027
211 THERAPEUTIC RESPONSE SHORTENED 90 0.0027
212 PSYCHIATRIC SYMPTOM 20 0.0027
213 WHEELCHAIR USER 12 0.0027
214 CONFUSIONAL STATE 434 0.0027
215 MALABSORPTION 14 0.0027
216 HICCUPS 22 0.0027
217 CHRONIC SINUSITIS 10 0.0027
218 BEDRIDDEN 35 0.0027
219 SOMNOLENCE 536 0.0027
220 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 127 0.0026
221 KNEE OPERATION 26 0.0026
222 MEMORY IMPAIRMENT 363 0.0026
223 FACE INJURY 10 0.0026
224 TROPONIN INCREASED 20 0.0026
225 DIABETIC NEUROPATHY 13 0.0026
226 LUMBAR VERTEBRAL FRACTURE 12 0.0026
227 CLAVICLE FRACTURE 10 0.0026
228 IMPAIRED QUALITY OF LIFE 37 0.0026
229 MANIA 42 0.0026
230 HAIR DISORDER 21 0.0025
231 PETIT MAL EPILEPSY 13 0.0025
232 SKIN MASS 17 0.0025
233 TERMINAL STATE 17 0.0025
234 WEIGHT FLUCTUATION 26 0.0025
235 AGGRESSION 124 0.0025
236 FINGER DEFORMITY 12 0.0025
237 INCOHERENT 16 0.0025
238 MAJOR DEPRESSION 18 0.0025
239 RENAL FAILURE 326 0.0025
240 INTERNAL HAEMORRHAGE 28 0.0024
241 MENTAL IMPAIRMENT 59 0.0024
242 DYSGRAPHIA 16 0.0024
243 CARPAL TUNNEL SYNDROME 34 0.0024
244 OVERWEIGHT 13 0.0024
245 URINARY TRACT INFECTION 411 0.0024
246 HIP SURGERY 13 0.0024
247 SPINAL OSTEOARTHRITIS 21 0.0024
248 HYPERGLYCAEMIA 87 0.0024
249 ACUTE KIDNEY INJURY 365 0.0024
250 NERVE COMPRESSION 22 0.0024
251 ARTHRITIS INFECTIVE 11 0.0024
252 NIGHTMARE 82 0.0024
253 HYPOPHAGIA 60 0.0023
254 INTENTIONAL UNDERDOSE 17 0.0023
255 SPINAL COMPRESSION FRACTURE 19 0.0023
256 DISORIENTATION 91 0.0023
257 DISTURBANCE IN ATTENTION 123 0.0023
258 BACK DISORDER 37 0.0023
259 JOINT DISLOCATION 24 0.0023
260 HYPERTONIA 13 0.0023
261 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 20 0.0023
262 ANKLE FRACTURE 35 0.0023
263 BLOOD URIC ACID INCREASED 13 0.0022
264 SOCIAL AVOIDANT BEHAVIOUR 13 0.0022
265 BLOOD COUNT ABNORMAL 34 0.0022
266 SENSORY LOSS 18 0.0022
267 SWELLING OF EYELID 14 0.0022
268 URINARY INCONTINENCE 66 0.0022
269 ANAL INCONTINENCE 20 0.0022
270 APHASIA 67 0.0022
271 BLADDER DISORDER 22 0.0022
272 DRUG EFFECT DELAYED 10 0.0022
273 AGITATION 162 0.0022
274 TIC 12 0.0022
275 MUSCULOSKELETAL STIFFNESS 192 0.0022
276 JAW DISORDER 12 0.0022
277 ROTATOR CUFF SYNDROME 28 0.0022
278 CEREBRAL DISORDER 16 0.0022
279 QUALITY OF LIFE DECREASED 29 0.0022
280 MUSCULOSKELETAL DISORDER 41 0.0022
281 RENAL FUNCTION TEST ABNORMAL 10 0.0022
282 HAEMORRHOIDS 42 0.0022
283 CHOKING 42 0.0022
284 HEART RATE ABNORMAL 12 0.0021
285 DEVICE DISLOCATION 93 0.0021
286 ATRIAL FLUTTER 17 0.0021
287 SLEEP DISORDER 150 0.0021
288 DYSARTHRIA 80 0.0021
289 GLOMERULAR FILTRATION RATE DECREASED 26 0.0021
290 SPINAL OPERATION 26 0.0021
291 PSYCHOMOTOR HYPERACTIVITY 35 0.0021
292 OSTEOPENIA 32 0.0021
293 TRANSIENT ISCHAEMIC ATTACK 71 0.0021
294 CATATONIA 11 0.0021
295 TOOTH FRACTURE 23 0.0021
296 DECUBITUS ULCER 17 0.0021
297 INSOMNIA 555 0.0021
298 LIMB DISCOMFORT 64 0.0021
299 LOCALISED INFECTION 50 0.0021
300 EATING DISORDER 44 0.0021
301 TARDIVE DYSKINESIA 58 0.0021
302 GASTROINTESTINAL MOTILITY DISORDER 11 0.0021
303 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 146 0.0021
304 UNEVALUABLE EVENT 155 0.0020
305 FEELING OF BODY TEMPERATURE CHANGE 12 0.0020
306 BLOOD PRESSURE FLUCTUATION 49 0.0020
307 CYSTITIS 65 0.0020
308 AFFECTIVE DISORDER 16 0.0020
309 BLOOD PRESSURE DIASTOLIC DECREASED 15 0.0020
310 DRUG EFFECT LESS THAN EXPECTED 30 0.0020
311 INABILITY TO AFFORD MEDICATION 20 0.0020
312 HAIR COLOUR CHANGES 25 0.0020
313 MUSCLE TWITCHING 46 0.0020
314 HYPERKERATOSIS 11 0.0020
315 TUBULOINTERSTITIAL NEPHRITIS 37 0.0020
316 BLOOD MAGNESIUM DECREASED 17 0.0020
317 HAEMODYNAMIC INSTABILITY 15 0.0020
318 FOOT FRACTURE 37 0.0019
319 DECREASED ACTIVITY 21 0.0019
320 ATAXIA 23 0.0019
321 SCOLIOSIS 12 0.0019
322 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 101 0.0019
323 DERMATITIS CONTACT 22 0.0019
324 PELVIC FRACTURE 15 0.0019
325 WRONG PRODUCT ADMINISTERED 13 0.0019
326 POLYNEUROPATHY 23 0.0019
327 UPPER GASTROINTESTINAL HAEMORRHAGE 32 0.0019
328 FOOD CRAVING 10 0.0019
329 LOWER GASTROINTESTINAL HAEMORRHAGE 14 0.0019
330 DEVICE USE ISSUE 33 0.0019
331 LEUKOCYTOSIS 34 0.0019
332 DECREASED INTEREST 11 0.0019
333 SLUGGISHNESS 19 0.0019
334 DRY MOUTH 151 0.0019
335 HYSTERECTOMY 16 0.0018
336 IRON DEFICIENCY ANAEMIA 17 0.0018
337 LIMB INJURY 50 0.0018
338 AORTIC ANEURYSM 14 0.0018
339 OEDEMA PERIPHERAL 224 0.0018
340 PRODUCT DOSE OMISSION IN ERROR 52 0.0018
341 WRIST FRACTURE 22 0.0018
342 WITHDRAWAL SYNDROME 77 0.0018
343 DEVICE ISSUE 164 0.0018
344 ACUTE RESPIRATORY FAILURE 35 0.0018
345 GRIP STRENGTH DECREASED 16 0.0018
346 APPETITE DISORDER 12 0.0018
347 LACERATION 17 0.0018
348 DYSPNOEA EXERTIONAL 68 0.0018
349 MUSCULAR WEAKNESS 204 0.0018
350 SEDATION 47 0.0018
351 SPUTUM DISCOLOURED 17 0.0018
352 PERIPHERAL SWELLING 276 0.0018
353 MUSCLE SPASTICITY 22 0.0018
354 POST-TRAUMATIC STRESS DISORDER 12 0.0018
355 ASTHMA 201 0.0018
356 ILEUS 22 0.0018
357 FIBROMYALGIA 43 0.0018
358 CONSTIPATION 385 0.0018
359 PRE-EXISTING CONDITION IMPROVED 11 0.0018
360 IMPAIRED DRIVING ABILITY 20 0.0018
361 SINUS BRADYCARDIA 17 0.0018
362 EXOSTOSIS 16 0.0018
363 HEAD DISCOMFORT 31 0.0017
364 ANHEDONIA 46 0.0017
365 THERAPEUTIC RESPONSE UNEXPECTED 78 0.0017
366 INTERVERTEBRAL DISC PROTRUSION 38 0.0017
367 LYMPHOEDEMA 12 0.0017
368 UROSEPSIS 16 0.0017
369 MYASTHENIA GRAVIS 14 0.0017
370 MOUTH SWELLING 10 0.0017
371 COMPLETED SUICIDE 144 0.0017
372 STAPHYLOCOCCAL INFECTION 57 0.0017
373 GOUT 31 0.0017
374 MUSCLE SPASMS 317 0.0017
375 DEPRESSION 393 0.0017
376 MOOD ALTERED 47 0.0017
377 COORDINATION ABNORMAL 24 0.0017
378 EXTRASYSTOLES 12 0.0017
379 SINUS DISORDER 34 0.0017
380 CONDITION AGGRAVATED 521 0.0017
381 SMALL INTESTINAL OBSTRUCTION 21 0.0017
382 OSTEOARTHRITIS 72 0.0017
383 SEASONAL ALLERGY 24 0.0017
384 RETCHING 36 0.0017
385 NEURALGIA 41 0.0017
386 KIDNEY INFECTION 33 0.0017
387 AMNESIA 109 0.0017
388 INTESTINAL OBSTRUCTION 63 0.0017
389 PRODUCT DOSE OMISSION 109 0.0017
390 DEPRESSED MOOD 88 0.0017
391 PANIC REACTION 12 0.0017
392 KNEE ARTHROPLASTY 35 0.0017
393 BACK INJURY 18 0.0017
394 PRESCRIBED OVERDOSE 32 0.0017
395 FLUID OVERLOAD 24 0.0016
396 HAIR TEXTURE ABNORMAL 22 0.0016
397 VITAMIN D DEFICIENCY 16 0.0016
398 HEART RATE IRREGULAR 37 0.0016
399 THERAPY CESSATION 84 0.0016
400 INFUSION SITE PAIN 21 0.0016
401 BLOOD POTASSIUM DECREASED 49 0.0016
402 MYOPATHY 14 0.0016
403 CARDIAC MURMUR 14 0.0016
404 FRUSTRATION TOLERANCE DECREASED 13 0.0016
405 POLLAKIURIA 67 0.0016
406 ASTHENIA 603 0.0016
407 PERIPHERAL COLDNESS 22 0.0016
408 ATRIAL FIBRILLATION 156 0.0016
409 OSTEOMYELITIS 29 0.0016
410 DYSPHAGIA 152 0.0016
411 PNEUMONIA ASPIRATION 40 0.0016
412 DRUG INTERACTION 253 0.0016
413 MYOCLONUS 19 0.0016
414 LOSS OF CONSCIOUSNESS 203 0.0016
415 SPINAL DISORDER 15 0.0016
416 NASAL CONGESTION 93 0.0016
417 OSTEOPOROSIS 65 0.0016
418 WEIGHT DECREASED 440 0.0016
419 HYPERTHERMIA 12 0.0016
420 DRUG DISPENSING ERROR 24 0.0016
421 FEELING ABNORMAL 376 0.0016
422 DEVICE PHYSICAL PROPERTY ISSUE 12 0.0016
423 POST PROCEDURAL COMPLICATION 30 0.0016
424 GASTROINTESTINAL INFECTION 14 0.0016
425 SINUS CONGESTION 21 0.0016
426 CONCUSSION 12 0.0015
427 INTENTIONAL DOSE OMISSION 44 0.0015
428 IMMUNODEFICIENCY 23 0.0015
429 HAEMOPTYSIS 43 0.0015
430 RED BLOOD CELL COUNT DECREASED 44 0.0015
431 DIZZINESS 767 0.0015
432 HYPERHIDROSIS 198 0.0015
433 SKIN LESION 42 0.0015
434 BRADYPHRENIA 10 0.0015
435 VITREOUS FLOATERS 15 0.0015
436 COVID-19 PNEUMONIA 18 0.0015
437 FEAR 41 0.0015
438 DEHYDRATION 203 0.0015
439 INCREASED APPETITE 29 0.0015
440 NEUROPATHY PERIPHERAL 144 0.0015
441 HAEMATOCRIT DECREASED 30 0.0015
442 ORAL DISCOMFORT 21 0.0015
443 PERSONALITY CHANGE 14 0.0015
444 HYPERLIPIDAEMIA 18 0.0015
445 CONTUSION 145 0.0015
446 BLOOD PRESSURE DECREASED 100 0.0015
447 THINKING ABNORMAL 28 0.0015
448 JOINT INJURY 32 0.0015
449 RESPIRATORY SYNCYTIAL VIRUS INFECTION 13 0.0015
450 LOCAL SWELLING 26 0.0015
451 DYSPHONIA 87 0.0015
452 DRUG EFFECT INCOMPLETE 54 0.0015
453 HYPOAESTHESIA 222 0.0015
454 FEEDING DISORDER 30 0.0015
455 PHARYNGITIS STREPTOCOCCAL 16 0.0015
456 ANXIETY 420 0.0015
457 BRONCHITIS 109 0.0015
458 TACHYPNOEA 20 0.0015
459 FEELING JITTERY 28 0.0015
460 ABNORMAL LOSS OF WEIGHT 10 0.0015
461 MADAROSIS 17 0.0015
462 DIPLOPIA 38 0.0015
463 BREAST TENDERNESS 11 0.0015
464 WRONG DRUG ADMINISTERED 13 0.0015
465 LOWER LIMB FRACTURE 28 0.0015
466 CARDIAC FAILURE CONGESTIVE 117 0.0015
467 HERNIA 28 0.0014
468 IRRITABILITY 87 0.0014
469 TOOTH INFECTION 19 0.0014
470 BACK PAIN 333 0.0014
471 SENSORY DISTURBANCE 23 0.0014
472 MASS 20 0.0014
473 MALNUTRITION 16 0.0014
474 CELLULITIS 72 0.0014
475 PRODUCT DISPENSING ERROR 31 0.0014
476 CANDIDA INFECTION 24 0.0014
477 MALIGNANT MELANOMA 19 0.0014
478 REBOUND EFFECT 16 0.0014
479 EMBEDDED DEVICE 14 0.0014
480 BLOOD PRESSURE ABNORMAL 28 0.0014
481 UPPER LIMB FRACTURE 28 0.0014
482 BRAIN FOG 22 0.0014
483 MYDRIASIS 18 0.0014
484 SCAB 16 0.0014
485 BURSITIS 17 0.0014
486 GALLBLADDER DISORDER 25 0.0014
487 RECTAL HAEMORRHAGE 60 0.0014
488 SKIN CANCER 30 0.0014
489 SKIN ULCER 36 0.0014
490 PULMONARY HYPERTENSION 29 0.0014
491 SYNCOPE 138 0.0014
492 PNEUMONIA 446 0.0014
493 MULTIPLE SCLEROSIS RELAPSE 94 0.0014
494 BLOOD URINE PRESENT 26 0.0014
495 EUPHORIC MOOD 14 0.0014
496 DYSURIA 50 0.0014
497 MUSCLE TIGHTNESS 22 0.0014
498 FLUID RETENTION 69 0.0014
499 DENTAL CARIES 15 0.0014
500 TREATMENT NONCOMPLIANCE 74 0.0014
501 EYE DISCHARGE 14 0.0013
502 HYPOTENSION 270 0.0013
503 SWOLLEN TONGUE 42 0.0013
504 TENDERNESS 14 0.0013
505 POLYURIA 11 0.0013
506 HEPATIC STEATOSIS 25 0.0013
507 HYPERAESTHESIA 11 0.0013
508 ROAD TRAFFIC ACCIDENT 56 0.0013
509 OXYGEN SATURATION DECREASED 75 0.0013
510 PAROSMIA 10 0.0013
511 THERAPY CHANGE 13 0.0013
512 RENAL PAIN 14 0.0013
513 AKATHISIA 18 0.0013
514 MELAENA 29 0.0013
515 THERAPY INTERRUPTED 94 0.0013
516 PAIN IN EXTREMITY 387 0.0013
517 HIATUS HERNIA 17 0.0013
518 PULMONARY ARTERIAL HYPERTENSION 19 0.0013
519 INSURANCE ISSUE 20 0.0013
520 COLD SWEAT 23 0.0013
521 HEREDITARY ANGIOEDEMA 14 0.0013
522 INCREASED TENDENCY TO BRUISE 12 0.0013
523 CARDIOMEGALY 16 0.0013
524 GRAND MAL CONVULSION 12 0.0013
525 EMOTIONAL DISORDER 40 0.0013
526 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 22 0.0013
527 THERAPEUTIC PRODUCT EFFECT DECREASED 58 0.0013
528 PRODUCT DISTRIBUTION ISSUE 12 0.0013
529 THIRST 23 0.0013
530 NEPHROPATHY 12 0.0013
531 HAEMATURIA 44 0.0013
532 AGEUSIA 32 0.0013
533 CLOSTRIDIUM DIFFICILE INFECTION 28 0.0013
534 PRODUCT DOSE OMISSION ISSUE 377 0.0013
535 GENERAL PHYSICAL HEALTH DETERIORATION 148 0.0013
536 PULMONARY MASS 19 0.0013
537 PSYCHOLOGICAL TRAUMA 11 0.0013
538 PRODUCT ADMINISTRATION INTERRUPTED 10 0.0013
539 ARTERIAL OCCLUSIVE DISEASE 10 0.0013
540 MUSCLE STRAIN 11 0.0013
541 FATIGUE 980 0.0013
542 PRODUCTIVE COUGH 60 0.0013
543 UPPER RESPIRATORY TRACT INFECTION 58 0.0013
544 SCIATICA 20 0.0013
545 HEART RATE DECREASED 44 0.0013
546 NECK PAIN 70 0.0013
547 SKIN INFECTION 14 0.0012
548 MENTAL DISORDER 54 0.0012
549 PANIC ATTACK 45 0.0012
550 GASTROINTESTINAL HAEMORRHAGE 103 0.0012
551 DECREASED APPETITE 286 0.0012
552 VISION BLURRED 169 0.0012
553 URINARY RETENTION 41 0.0012
554 DIVERTICULITIS 34 0.0012
555 PHARYNGEAL SWELLING 12 0.0012
556 BURNING SENSATION 86 0.0012
557 FEELING HOT 75 0.0012
558 RENAL TUBULAR NECROSIS 12 0.0012
559 CARDIOVASCULAR DISORDER 31 0.0012
560 HOT FLUSH 92 0.0012
561 ARTHRITIS 96 0.0012
562 BLOOD SODIUM DECREASED 23 0.0012
563 COUGH 342 0.0012
564 BREAST PAIN 13 0.0012
565 VISUAL IMPAIRMENT 151 0.0012
566 APHONIA 17 0.0012
567 COVID-19 213 0.0012
568 OPTIC NEURITIS 11 0.0012
569 WEIGHT INCREASED 271 0.0012
570 TOOTH EXTRACTION 15 0.0012
571 HYPOTONIA 12 0.0012
572 PANCREATITIS ACUTE 27 0.0012
573 SINUSITIS 123 0.0012
574 FUNGAL INFECTION 40 0.0012
575 WHITE BLOOD CELL COUNT INCREASED 46 0.0012
576 NEUROTOXICITY 21 0.0012
577 SPINAL FRACTURE 24 0.0012
578 SPINAL PAIN 14 0.0012
579 GLAUCOMA 23 0.0012
580 MULTIPLE SCLEROSIS 57 0.0012
581 FULL BLOOD COUNT DECREASED 24 0.0012
582 MEDICATION ERROR 66 0.0012
583 WOUND INFECTION 13 0.0012
584 EXTRA DOSE ADMINISTERED 48 0.0012
585 CRYING 43 0.0012
586 WOUND 33 0.0012
587 SEPSIS 131 0.0012
588 BLOOD POTASSIUM INCREASED 19 0.0012
589 SQUAMOUS CELL CARCINOMA 11 0.0012
590 CORONARY ARTERY OCCLUSION 16 0.0012
591 HYPOXIA 41 0.0012
592 PROSTATIC SPECIFIC ANTIGEN INCREASED 16 0.0012
593 RESPIRATORY ARREST 32 0.0012
594 NAUSEA 916 0.0012
595 PARAESTHESIA 182 0.0012
596 HUNGER 16 0.0011
597 ADVERSE DRUG REACTION 103 0.0011
598 TRANSFUSION 12 0.0011
599 AFFECT LABILITY 11 0.0011
600 NAIL DISORDER 10 0.0011
601 CATARACT 68 0.0011
602 CHOLECYSTECTOMY 13 0.0011
603 SCRATCH 12 0.0011
604 ERUCTATION 22 0.0011
605 BLOOD UREA INCREASED 19 0.0011
606 THERAPY NON-RESPONDER 51 0.0011
607 TENDON RUPTURE 14 0.0011
608 OBESITY 18 0.0011
609 FLATULENCE 64 0.0011
610 DYSPEPSIA 111 0.0011
611 RHABDOMYOLYSIS 47 0.0011
612 ILLNESS 116 0.0011
613 TOOTH DISORDER 25 0.0011
614 INTENTIONAL PRODUCT MISUSE 98 0.0011
615 ELECTROLYTE IMBALANCE 13 0.0011
616 NIGHT SWEATS 36 0.0011
617 MALAISE 490 0.0011
618 ACTIVITIES OF DAILY LIVING IMPAIRED 22 0.0011
619 HIP ARTHROPLASTY 17 0.0011
620 SPLENOMEGALY 13 0.0011
621 DEVICE BREAKAGE 45 0.0011
622 GASTROENTERITIS VIRAL 20 0.0011
623 DEVICE RELATED INFECTION 17 0.0011
624 RESPIRATORY DISORDER 33 0.0011
625 INFLUENZA 123 0.0011
626 DYSPNOEA 624 0.0011
627 LETHARGY 63 0.0011
628 EXTRAPYRAMIDAL DISORDER 27 0.0011
629 LABORATORY TEST ABNORMAL 32 0.0011
630 DEVICE LEAKAGE 47 0.0011
631 PRODUCT USE COMPLAINT 17 0.0011
632 BLOOD CREATINE PHOSPHOKINASE INCREASED 31 0.0011
633 LYMPHOCYTE COUNT DECREASED 19 0.0011
634 PAIN 660 0.0011
635 ABDOMINAL DISTENSION 112 0.0011
636 DRUG WITHDRAWAL SYNDROME 94 0.0011
637 FEMUR FRACTURE 33 0.0011
638 CEREBRAL HAEMORRHAGE 38 0.0011
639 ABDOMINAL DISCOMFORT 178 0.0011
640 MITRAL VALVE INCOMPETENCE 12 0.0011
641 SARS-COV-2 TEST POSITIVE 14 0.0011
642 VENTRICULAR EXTRASYSTOLES 11 0.0011
643 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 58 0.0011
644 CHEST PAIN 195 0.0011
645 MICTURITION URGENCY 12 0.0010
646 SUICIDAL IDEATION 96 0.0010
647 PARALYSIS 15 0.0010
648 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 10 0.0010
649 SWELLING 98 0.0010
650 MUSCULOSKELETAL DISCOMFORT 18 0.0010
651 JOINT RANGE OF MOTION DECREASED 14 0.0010
652 GASTRIC HAEMORRHAGE 12 0.0010
653 BONE PAIN 61 0.0010
654 PARAESTHESIA ORAL 15 0.0010
655 TASTE DISORDER 21 0.0010
656 POST PROCEDURAL HAEMORRHAGE 12 0.0010
657 HOSPITALISATION 158 0.0010
658 GENERALISED TONIC-CLONIC SEIZURE 17 0.0010
659 ORAL PAIN 23 0.0010
660 NEPHROLITHIASIS 47 0.0010
661 HAEMOGLOBIN DECREASED 105 0.0010
662 CEREBROVASCULAR ACCIDENT 173 0.0010
663 ENCEPHALOPATHY 25 0.0010
664 BLISTER 57 0.0010
665 NERVOUSNESS 53 0.0010
666 OEDEMA 55 0.0010
667 ABASIA 25 0.0010
668 ARTHROPATHY 56 0.0010
669 PRODUCT SUBSTITUTION ISSUE 58 0.0010
670 RESPIRATORY TRACT CONGESTION 16 0.0010
671 BLOOD ALKALINE PHOSPHATASE INCREASED 25 0.0010
672 HYPOMAGNESAEMIA 14 0.0010
673 CARDIAC ARREST 83 0.0010
674 HYPOCALCAEMIA 19 0.0010
675 HEMIPARESIS 17 0.0010
676 UNDERDOSE 73 0.0010
677 GASTROINTESTINAL PAIN 11 0.0010
678 RESPIRATORY TRACT INFECTION 26 0.0010
679 HYPOAESTHESIA ORAL 15 0.0010
680 BLOOD PRESSURE INCREASED 152 0.0010
681 BLINDNESS UNILATERAL 14 0.0010
682 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 17 0.0010
683 DIARRHOEA 640 0.0010
684 NERVE INJURY 11 0.0010
685 PRESYNCOPE 24 0.0010
686 PULMONARY OEDEMA 44 0.0010
687 ARTHRALGIA 407 0.0010
688 VOMITING 460 0.0010
689 SEIZURE 113 0.0010
690 RESPIRATORY DISTRESS 27 0.0010
691 RENAL IMPAIRMENT 82 0.0010
692 HYPOKALAEMIA 45 0.0010
693 BLOOD GLUCOSE ABNORMAL 18 0.0010
694 CARDIAC DISORDER 91 0.0010
695 MOOD SWINGS 31 0.0010
696 SURGERY 57 0.0010
697 FEELING COLD 27 0.0010
698 INCORRECT PRODUCT ADMINISTRATION DURATION 21 0.0010
699 FAECES DISCOLOURED 21 0.0010
700 CYST 12 0.0010
701 COMPLICATION ASSOCIATED WITH DEVICE 14 0.0010
702 MIGRAINE 92 0.0010
703 JOINT SWELLING 116 0.0010
704 COAGULOPATHY 16 0.0010
705 PHOTOPHOBIA 18 0.0010
706 DRUG EFFECT DECREASED 51 0.0009
707 ULCER 15 0.0009
708 PRODUCT PHYSICAL ISSUE 19 0.0009
709 FLUSHING 95 0.0009
710 C-REACTIVE PROTEIN INCREASED 34 0.0009
711 DRUG INEFFECTIVE 1227 0.0009
712 RHINORRHOEA 60 0.0009
713 WHEEZING 55 0.0009
714 LACRIMATION INCREASED 28 0.0009
715 EAR PAIN 18 0.0009
716 EPISTAXIS 69 0.0009
717 ORAL HERPES 18 0.0009
718 PULMONARY THROMBOSIS 10 0.0009
719 ANGER 31 0.0009
720 MUSCULOSKELETAL PAIN 48 0.0009
721 SINUS TACHYCARDIA 13 0.0009
722 HYPERKALAEMIA 32 0.0009
723 TACHYCARDIA 81 0.0009
724 ORAL CANDIDIASIS 12 0.0009
725 CHEST DISCOMFORT 93 0.0009
726 BLINDNESS 37 0.0009
727 HYPERTENSION 192 0.0009
728 HERPES ZOSTER 52 0.0009
729 EAR INFECTION 24 0.0009
730 MYALGIA 153 0.0009
731 FRACTURE 17 0.0009
732 ANOSMIA 13 0.0009
733 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 161 0.0009
734 RESPIRATORY FAILURE 65 0.0009
735 BLOOD CREATININE INCREASED 58 0.0009
736 HAEMATOCHEZIA 49 0.0009
737 THROAT TIGHTNESS 24 0.0009
738 HEADACHE 556 0.0009
739 OROPHARYNGEAL PAIN 82 0.0009
740 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 63 0.0009
741 TOOTHACHE 16 0.0009
742 GINGIVAL BLEEDING 12 0.0009
743 SECRETION DISCHARGE 11 0.0009
744 SKIN HAEMORRHAGE 13 0.0009
745 JOINT STIFFNESS 23 0.0009
746 SCAR 15 0.0009
747 ABDOMINAL PAIN UPPER 180 0.0009
748 GASTRITIS 23 0.0009
749 CENTRAL NERVOUS SYSTEM LESION 12 0.0009
750 MYOCARDITIS 10 0.0009
751 CARDIAC FAILURE 70 0.0009
752 GLYCOSYLATED HAEMOGLOBIN INCREASED 22 0.0009
753 LIP SWELLING 29 0.0009
754 SHOCK 20 0.0009
755 VERTIGO 53 0.0009
756 DISCOMFORT 53 0.0009
757 EYE PAIN 49 0.0009
758 INFECTION 125 0.0009
759 ALOPECIA 169 0.0009
760 INTENTIONAL PRODUCT USE ISSUE 75 0.0009
761 ABDOMINAL PAIN 199 0.0009
762 CHOLELITHIASIS 28 0.0009
763 MULTIPLE FRACTURES 14 0.0009
764 HEPATIC CIRRHOSIS 16 0.0009
765 PAIN IN JAW 24 0.0008
766 DRUG DOSE OMISSION 140 0.0008
767 CHILLS 99 0.0008
768 METABOLIC ACIDOSIS 27 0.0008
769 THYROID DISORDER 13 0.0008
770 NODULE 11 0.0008
771 CHROMATURIA 19 0.0008
772 DRY EYE 42 0.0008
773 PRODUCT ADMINISTRATION ERROR 17 0.0008
774 LYMPHOMA 13 0.0008
775 PRODUCT USE ISSUE 158 0.0008
776 PRODUCT PRESCRIBING ERROR 20 0.0008
777 SUBDURAL HAEMATOMA 12 0.0008
778 HEART RATE INCREASED 83 0.0008
779 MACULAR DEGENERATION 10 0.0008
780 BLOOD GLUCOSE DECREASED 40 0.0008
781 THROMBOSIS 67 0.0008
782 SKIN DISCOLOURATION 38 0.0008
783 STOMATITIS 50 0.0008
784 BONE DISORDER 15 0.0008
785 PLEURAL EFFUSION 50 0.0008
786 COMA 39 0.0008
787 ANAEMIA 156 0.0008
788 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 38 0.0008
789 HYPOACUSIS 35 0.0008
790 PSORIATIC ARTHROPATHY 33 0.0008
791 PRODUCT ADHESION ISSUE 29 0.0008
792 VIRAL INFECTION 27 0.0008
793 INJURY 57 0.0008
794 BRADYCARDIA 43 0.0008
795 THERAPEUTIC RESPONSE DECREASED 49 0.0008
796 PLATELET COUNT DECREASED 86 0.0008
797 INTERNATIONAL NORMALISED RATIO INCREASED 23 0.0008
798 ILL-DEFINED DISORDER 49 0.0008
799 SNEEZING 18 0.0008
800 HYPONATRAEMIA 45 0.0008
801 METASTASES TO LIVER 14 0.0008
802 PROCEDURAL PAIN 22 0.0008
803 IRRITABLE BOWEL SYNDROME 17 0.0008
804 LIVER FUNCTION TEST INCREASED 17 0.0008
805 BRAIN OEDEMA 10 0.0008
806 GASTRIC ULCER 15 0.0008
807 PROTEINURIA 15 0.0008
808 DEATH 677 0.0008
809 PRODUCT PRESCRIBING ISSUE 17 0.0008
810 PHARYNGEAL OEDEMA 12 0.0008
811 PERICARDIAL EFFUSION 18 0.0008
812 MUSCULOSKELETAL CHEST PAIN 12 0.0008
813 WHITE BLOOD CELL COUNT DECREASED 84 0.0008
814 TOOTH LOSS 16 0.0008
815 NASOPHARYNGITIS 142 0.0008
816 ANGINA PECTORIS 22 0.0008
817 PLATELET COUNT INCREASED 10 0.0008
818 HAND DEFORMITY 10 0.0008
819 SUICIDE ATTEMPT 46 0.0008
820 DISABILITY 15 0.0008
821 RENAL FAILURE ACUTE 32 0.0008
822 EXPIRED PRODUCT ADMINISTERED 25 0.0008
823 RENAL DISORDER 35 0.0008
824 EYE HAEMORRHAGE 10 0.0007
825 ADVERSE EVENT 69 0.0007
826 ERECTILE DYSFUNCTION 19 0.0007
827 COLON CANCER 11 0.0007
828 NERVOUS SYSTEM DISORDER 23 0.0007
829 BODY TEMPERATURE INCREASED 15 0.0007
830 DIABETES MELLITUS 56 0.0007
831 HAEMATOMA 19 0.0007
832 APPLICATION SITE RASH 10 0.0007
833 PRODUCT USE IN UNAPPROVED INDICATION 180 0.0007
834 PRURITUS 279 0.0007
835 VISUAL ACUITY REDUCED 24 0.0007
836 SKIN DISORDER 24 0.0007
837 CARDIO-RESPIRATORY ARREST 30 0.0007
838 HAEMORRHAGE 75 0.0007
839 INTENTIONAL OVERDOSE 46 0.0007
840 SKIN FISSURES 14 0.0007
841 RASH MACULAR 25 0.0007
842 DISEASE RECURRENCE 34 0.0007
843 DRUG INTOLERANCE 69 0.0007
844 THROAT IRRITATION 32 0.0007
845 TENDONITIS 11 0.0007
846 DEPRESSED LEVEL OF CONSCIOUSNESS 28 0.0007
847 THERAPY PARTIAL RESPONDER 11 0.0007
848 FREQUENT BOWEL MOVEMENTS 19 0.0007
849 RASH PRURITIC 38 0.0007
850 PRODUCT QUALITY ISSUE 95 0.0007
851 EYE IRRITATION 40 0.0007
852 BLOOD LACTATE DEHYDROGENASE INCREASED 11 0.0007
853 INFUSION RELATED REACTION 46 0.0007
854 PSORIASIS 90 0.0007
855 EPILEPSY 21 0.0007
856 EMOTIONAL DISTRESS 83 0.0007
857 OFF LABEL USE 596 0.0007
858 INFLUENZA LIKE ILLNESS 56 0.0007
859 HYPERSENSITIVITY 126 0.0007
860 CARDIOMYOPATHY 10 0.0007
861 SWELLING FACE 44 0.0007
862 DYSGEUSIA 50 0.0007
863 HAEMATEMESIS 17 0.0007
864 INCORRECT DOSE ADMINISTERED 153 0.0007
865 EYE DISORDER 22 0.0007
866 SKIN EXFOLIATION 56 0.0007
867 PANCREATITIS 35 0.0007
868 DEEP VEIN THROMBOSIS 43 0.0007
869 CORONARY ARTERY DISEASE 20 0.0007
870 MYOCARDIAL INFARCTION 115 0.0007
871 PRODUCT AVAILABILITY ISSUE 15 0.0007
872 HYPOTHYROIDISM 21 0.0007
873 PALPITATIONS 77 0.0007
874 DEVICE DELIVERY SYSTEM ISSUE 18 0.0007
875 OCULAR HYPERAEMIA 31 0.0007
876 TINNITUS 30 0.0007
877 PULMONARY EMBOLISM 62 0.0007
878 DEVICE DIFFICULT TO USE 43 0.0006
879 DRUG ABUSE 54 0.0006
880 GASTROINTESTINAL DISORDER 58 0.0006
881 EYE SWELLING 24 0.0006
882 BACTERIAL INFECTION 12 0.0006
883 BASAL CELL CARCINOMA 10 0.0006
884 IMPAIRED HEALING 21 0.0006
885 BONE DENSITY DECREASED 20 0.0006
886 DISEASE PROGRESSION 75 0.0006
887 WRONG TECHNIQUE IN DRUG USAGE PROCESS 23 0.0006
888 TRANSAMINASES INCREASED 14 0.0006
889 PALLOR 17 0.0006
890 RASH PAPULAR 14 0.0006
891 INJECTION SITE MASS 23 0.0006
892 RASH 271 0.0006
893 DERMATITIS 13 0.0006
894 BLOOD PRESSURE SYSTOLIC INCREASED 12 0.0006
895 INJECTION SITE BRUISING 49 0.0006
896 LUNG DISORDER 30 0.0006
897 IMPAIRED WORK ABILITY 13 0.0006
898 COLITIS 23 0.0006
899 OVERDOSE 130 0.0006
900 PRURITUS GENERALISED 13 0.0006
901 BLOOD CHOLESTEROL INCREASED 28 0.0006
902 ELECTROCARDIOGRAM QT PROLONGED 21 0.0006
903 GLOSSODYNIA 13 0.0006
904 BLOOD GLUCOSE INCREASED 109 0.0006
905 DEVICE DEFECTIVE 10 0.0006
906 APPLICATION SITE PRURITUS 13 0.0006
907 RHEUMATOID ARTHRITIS 65 0.0006
908 INJECTION SITE ERYTHEMA 71 0.0006
909 APPLICATION SITE ERYTHEMA 15 0.0006
910 INCORRECT DOSE ADMINISTERED BY DEVICE 15 0.0006
911 LYMPHADENOPATHY 20 0.0006
912 MULTIPLE ORGAN DYSFUNCTION SYNDROME 16 0.0006
913 TOXICITY TO VARIOUS AGENTS 95 0.0006
914 PYREXIA 194 0.0006
915 NEOPLASM MALIGNANT 37 0.0006
916 LIVER FUNCTION TEST ABNORMAL 16 0.0005
917 LOWER RESPIRATORY TRACT INFECTION 25 0.0005
918 NEEDLE ISSUE 16 0.0005
919 DEVICE MALFUNCTION 38 0.0005
920 ERYTHEMA 111 0.0005
921 DEAFNESS 14 0.0005
922 SEPTIC SHOCK 23 0.0005
923 GASTRIC DISORDER 18 0.0005
924 DRUG ADMINISTRATION ERROR 16 0.0005
925 HYPOGLYCAEMIA 25 0.0005
926 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 104 0.0005
927 THROMBOCYTOPENIA 57 0.0005
928 ACUTE MYOCARDIAL INFARCTION 15 0.0005
929 ASPARTATE AMINOTRANSFERASE INCREASED 27 0.0005
930 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
931 HEPATIC ENZYME INCREASED 34 0.0005
932 INJECTION SITE REACTION 34 0.0005
933 HEPATOTOXICITY 11 0.0005
934 CONVULSION 28 0.0005
935 ARRHYTHMIA 23 0.0005
936 INFLAMMATION 25 0.0005
937 LEUKOPENIA 24 0.0005
938 ABDOMINAL PAIN LOWER 12 0.0005
939 INJECTION SITE PRURITUS 31 0.0005
940 PLASMA CELL MYELOMA 18 0.0005
941 INJECTION SITE PAIN 141 0.0005
942 ALANINE AMINOTRANSFERASE INCREASED 28 0.0005
943 DERMATITIS ATOPIC 24 0.0005
944 INJECTION SITE HAEMORRHAGE 36 0.0005
945 DRY SKIN 60 0.0004
946 INJECTION SITE URTICARIA 11 0.0004
947 URTICARIA 75 0.0004
948 LUNG NEOPLASM MALIGNANT 18 0.0004
949 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 11 0.0004
950 SYSTEMIC LUPUS ERYTHEMATOSUS 15 0.0004
951 GYNAECOMASTIA 13 0.0004
952 INJECTION SITE SWELLING 32 0.0004
953 ACCIDENTAL OVERDOSE 15 0.0004
954 NEUTROPENIA 55 0.0004
955 PNEUMONITIS 11 0.0004
956 ECZEMA 21 0.0004
957 CONTRAINDICATED PRODUCT ADMINISTERED 12 0.0004
958 OSTEONECROSIS 13 0.0004
959 SKIN IRRITATION 18 0.0004
960 EYE PRURITUS 13 0.0004
961 RASH GENERALISED 10 0.0004
962 EXPOSURE VIA SKIN CONTACT 10 0.0004
963 ANGIOEDEMA 17 0.0004
964 ASCITES 11 0.0004
965 JAUNDICE 10 0.0004
966 VAGINAL HAEMORRHAGE 16 0.0004
967 LIVER DISORDER 16 0.0004
968 INCORRECT DRUG ADMINISTRATION DURATION 10 0.0004
969 PANCREATIC CARCINOMA 10 0.0003
970 ANAPHYLACTIC REACTION 19 0.0003
971 PANCYTOPENIA 19 0.0003
972 INJECTION SITE RASH 10 0.0003
973 TREATMENT FAILURE 26 0.0003
974 ACCIDENTAL EXPOSURE TO PRODUCT 32 0.0003
975 NO ADVERSE EVENT 56 0.0003
976 INCORRECT ROUTE OF DRUG ADMINISTRATION 11 0.0003
977 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 10 0.0003
978 RASH ERYTHEMATOUS 14 0.0003
979 DEPENDENCE 16 0.0003
980 PRODUCT STORAGE ERROR 25 0.0003
981 SKIN BURNING SENSATION 20 0.0003
982 BREAST CANCER 23 0.0002
983 COLITIS ULCERATIVE 11 0.0002
984 FEBRILE NEUTROPENIA 16 0.0002
985 DRUG DOSE OMISSION BY DEVICE 18 0.0002
986 MALIGNANT NEOPLASM PROGRESSION 23 0.0002
987 PROSTATE CANCER 17 0.0002
988 ACNE 16 0.0002
989 INTERSTITIAL LUNG DISEASE 10 0.0002
990 BLADDER CANCER 11 0.0002
991 DRUG DEPENDENCE 30 0.0002